Zhou E - Search Results

1

FGF21 protects against hepatic lipotoxicity and macrophage activation to attenuate fibrogenesis in nonalcoholic steatohepatitis.

Liu C, Schönke M, Spoorenberg B, Lambooij JM, van der Zande HJP, Zhou E, Tushuizen ME, Andreasson AC, Park A, Oldham S, Uhrbom M, Ahlstedt I, Ikeda Y, Wallenius K, Peng XR, Guigas B, Boon MR, Wang Y, Rensen PCN. Liu C, et al. Among authors: zhou e. Elife. 2023 Jan 17;12:e83075. doi: 10.7554/eLife.83075. Elife. 2023. PMID: 36648330 Free PMC article.

2

Butyrate reduces appetite and activates brown adipose tissue via the gut-brain neural circuit.

Li Z, Yi CX, Katiraei S, Kooijman S, Zhou E, Chung CK, Gao Y, van den Heuvel JK, Meijer OC, Berbée JFP, Heijink M, Giera M, Willems van Dijk K, Groen AK, Rensen PCN, Wang Y. Li Z, et al. Among authors: zhou e. Gut. 2018 Jul;67(7):1269-1279. doi: 10.1136/gutjnl-2017-314050. Epub 2017 Nov 3. Gut. 2018. PMID: 29101261

3

Inhibition of Δ24-dehydrocholesterol reductase activates pro-resolving lipid mediator biosynthesis and inflammation resolution.

Körner A, Zhou E, Müller C, Mohammed Y, Herceg S, Bracher F, Rensen PCN, Wang Y, Mirakaj V, Giera M. Körner A, et al. Among authors: zhou e. Proc Natl Acad Sci U S A. 2019 Oct 8;116(41):20623-20634. doi: 10.1073/pnas.1911992116. Epub 2019 Sep 23. Proc Natl Acad Sci U S A. 2019. PMID: 31548397 Free PMC article.

4

Colesevelam enhances the beneficial effects of brown fat activation on hyperlipidaemia and atherosclerosis development.

Zhou E, Hoeke G, Li Z, Eibergen AC, Schonk AW, Koehorst M, Boverhof R, Havinga R, Kuipers F, Coskun T, Boon MR, Groen AK, Rensen PCN, Berbée JFP, Wang Y. Zhou E, et al. Cardiovasc Res. 2020 Aug 1;116(10):1710-1720. doi: 10.1093/cvr/cvz253. Cardiovasc Res. 2020. PMID: 31589318 Free PMC article.

5

Deletion of haematopoietic Dectin-2 or CARD9 does not protect from atherosclerosis development under hyperglycaemic conditions.

Thiem K, Hoeke G, Zhou E, Hijmans A, Houben T, Boels MG, Mol IM, Lutgens E, Shiri-Sverdlov R, Bussink J, Kanneganti TD, Boon MR, Stienstra R, Tack CJ, Rensen PC, Netea MG, Berbée JF, van Diepen JA. Thiem K, et al. Among authors: zhou e. Diab Vasc Dis Res. 2020 Jan-Feb;17(1):1479164119892140. doi: 10.1177/1479164119892140. Epub 2019 Dec 23. Diab Vasc Dis Res. 2020. PMID: 31868000 Free PMC article.

6

Hepatic Scavenger Receptor Class B Type 1 Knockdown Reduces Atherosclerosis and Enhances the Antiatherosclerotic Effect of Brown Fat Activation in APOE*3-Leiden.CETP Mice.

Zhou E, Li Z, Nakashima H, Liu C, Ying Z, Foks AC, Berbée JFP, van Dijk KW, Rensen PCN, Wang Y. Zhou E, et al. Arterioscler Thromb Vasc Biol. 2021 Apr;41(4):1474-1486. doi: 10.1161/ATVBAHA.121.315882. Epub 2021 Feb 11. Arterioscler Thromb Vasc Biol. 2021. PMID: 33567866

7

Beneficial effects of brown fat activation on top of PCSK9 inhibition with alirocumab on dyslipidemia and atherosclerosis development in APOE*3-Leiden.CETP mice.

Zhou E, Li Z, Nakashima H, Choukoud A, Kooijman S, Berbée JFP, Rensen PCN, Wang Y. Zhou E, et al. Pharmacol Res. 2021 May;167:105524. doi: 10.1016/j.phrs.2021.105524. Epub 2021 Mar 2. Pharmacol Res. 2021. PMID: 33667684 Free article.

8

Pharmacological treatment with FGF21 strongly improves plasma cholesterol metabolism to reduce atherosclerosis.

Liu C, Schönke M, Zhou E, Li Z, Kooijman S, Boon MR, Larsson M, Wallenius K, Dekker N, Barlind L, Peng XR, Wang Y, Rensen PCN. Liu C, et al. Among authors: zhou e. Cardiovasc Res. 2022 Jan 29;118(2):489-502. doi: 10.1093/cvr/cvab076. Cardiovasc Res. 2022. PMID: 33693480 Free PMC article.

9

Role of thermogenic adipose tissue in lipid metabolism and atherosclerotic cardiovascular disease: lessons from studies in mice and humans.

Ying Z, Tramper N, Zhou E, Boon MR, Rensen PCN, Kooijman S. Ying Z, et al. Among authors: zhou e. Cardiovasc Res. 2023 May 2;119(4):905-918. doi: 10.1093/cvr/cvac131. Cardiovasc Res. 2023. PMID: 35944189 Free PMC article. Review.

10

Inhibition of DHCR24 activates LXRα to ameliorate hepatic steatosis and inflammation.

Zhou E, Ge X, Nakashima H, Li R, van der Zande HJP, Liu C, Li Z, Müller C, Bracher F, Mohammed Y, de Boer JF, Kuipers F, Guigas B, Glass CK, Rensen PCN, Giera M, Wang Y. Zhou E, et al. EMBO Mol Med. 2023 Aug 7;15(8):e16845. doi: 10.15252/emmm.202216845. Epub 2023 Jun 26. EMBO Mol Med. 2023. PMID: 37357756 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,136 results

Search Page